Initial group of patients have received Saphnelo in a phase 3 trial evaluating lupus nephritis
Updated Date: Thu, 19 May 2022 00:00:00 EDT
Updated Date: Thu, 19 May 2022 00:00:00 EDT
A synthesized antibiotic derived from computer models of bacterial gene products appears to neutralize even drug-resistant bacteria. The […]
The world of prediabetes, where no one can hear you screenI remember those joyous early years after it […]
A GP who was found guilty of 54 sex offences against female patients over three and a half […]
Sunday would normally be a day of peace, but this weekend it was anything but. The case of […]
It was a breath of fresh air to read Cox and Fritz’s description of how language shapes doctors’ […]
The health crisis for migrants crossing the Darién Gap is getting worse as the number of people crossing […]
Libtayo has been approved for adults when curative surgery or radiation is not appropriate